Siqi Yin

885 citations
13 papers · 703 indexed · 1 hit paper · h-index 9
Topics
Extracellular vesicles in disease (6 papers)Mesenchymal stem cell research (2 papers)MicroRNA in disease regulation (2 papers)
Partner nations
China

In The Last Decade

Siqi Yin

13 papers receiving 701 citations

Hit Papers

Human Mesenchymal Stem Cell Derived Exosomes Alleviate Ty...20182026202020232018100200300

Peers

Siqi Yin
Comparison fields: 5 of 83
  • Molecular Biology 507
  • Cancer Research 243
  • Genetics 143
  • Surgery 107
  • Immunology 61
Replace Fengqi Duan with:
Fengqi Duan China
Heli Xiang China
Alvin Tieu Canada
Md Sanaullah Sajib United States
Ying Xie China
Chuan Wen China
Ming-Hui Zheng China
Xuemei Yu China
Vitale Miceli Italy
Siqi Yin relative to Fengqi Duan China Fengqi Duan's profile →
Citations per field
00.5×1.7×
Fengqi Duan · 1×
Citations per year

Countries citing papers authored by Siqi Yin

Since Specialization
Citations

This map shows the geographic impact of Siqi Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siqi Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siqi Yin more than expected).

Fields of papers citing papers by Siqi Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siqi Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siqi Yin. The network helps show where Siqi Yin may publish in the future.

Co-authorship network of co-authors of Siqi Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Siqi Yin. A scholar is included among the top collaborators of Siqi Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siqi Yin. Siqi Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 2
2 2
3 12
4 13
5 12
6 31
7 91
8 77
9
Human umbilical cord mesenchymal stem cells and exosomes: bioactive ways of tissue injury repair.
80
10
Human Mesenchymal Stem Cell Derived Exosomes Alleviate Type 2 Diabetes Mellitus by Reversing Peripheral Insulin Resistance and Relieving β-Cell Destructionbreakdown →
354
11 8
12 13
13 8

About Siqi Yin

Siqi Yin is a scholar working on Nephrology, Cancer Research and Genetics, having authored 13 papers that have together received 703 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (6 papers), Mesenchymal stem cell research (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (243 citations), Genetics (143 citations) and Molecular Biology (507 citations). Siqi Yin has collaborated with scholars based in China. Frequent co-authors include Cheng Ji, Hui Qian, Peipei Wu, Wenrong Xu, Hui Shi, Xu Zhang, Yongmin Yan, Bin Zhang, Yaoxiang Sun and Ying‐Hong Shi. Their work appears in journals such as ACS Nano, Scientific Reports and Cell Death and Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026